Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents [PDF]
Medicina, 2022 Systemic inflammation represents a shared pathophysiological mechanism which underlies the frequent clinical associations among chronic inflammatory rheumatic diseases (CIRDs), insulin resistance, type 2 diabetes (T2D), and chronic diabetes complications,
Marco Infante +6 more
doaj +5 more sources
Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis. [PDF]
Front Endocrinol (Lausanne), 2017 With the increased pro-inflammatory response in both rheumatoid arthritis and thyroid autoimmune diseases, treatment with biological antirheumatic agents (BAAs) of the former may affect the course of the latter. In hepatitis C and cancer patients, treatment with biological agents substantially increases the risk of developing thyroid autoimmunity.
Bliddal S +2 more
europepmc +9 more sources
Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents. [PDF]
JAMA Netw Open, 2022 Desai RJ +9 more
europepmc +2 more sources
Evaluation of impaired growth plate development of long bones in skeletally immature mice by antirheumatic agents. [PDF]
J Orthop Res, 2021 Caron MMJ +6 more
europepmc +3 more sources
Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review. [PDF]
PLoS ONEThe safety of antirheumatic drugs in pregnancy and their impact on maternal and neonatal outcomes are understudied. Despite pregnant individuals being excluded from clinical trials, their continued use of medications raises the importance of addressing ...
Shenthuraan Tharmarajah +7 more
doaj +2 more sources
153 Do Hydroxychloroquine, Disease-Modifying Antirheumatic Agents or Steroids, Serve to Prevent COVID-19 Infection? [PDF]
Ann Emerg Med, 2020 Daniel C. Keyes +4 more
europepmc +3 more sources
Effects of Abatacept in patients with rheumatoid arthritis and cancer risk [PDF]
Reviews in Clinical Medicine, 2023 Introduction: As a chronic autoimmune disease, Rheumatoid arthritis (RA) affects the joints. Studies have shown a complex and challenging link between cancer and RA.
Saba Homapoor +2 more
doaj +1 more source
Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims The aim of this study was to investigate long-term post-discontinuation outcomes in patients with rheumatoid arthritis (RA) who had been treated with tumor necrosis factor-α inhibitors (TNF-αi) which was then discontinued.
Kichul Shin +14 more
doaj +1 more source
Arthritis Research & Therapy, 2023 Background This study sought to evaluate the efficacy and safety of tofacitinib in patients with rheumatoid arthritis with distinct treatment histories. Methods Pooled phase II/III trial data from patients who received tofacitinib 5 or 10 mg twice daily ...
John Tesser +6 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Cardiovascular disease is the most common cause of death in patients with rheumatoid arthritis. It is believed that using disease‐modifying antirheumatic drugs (DMARDs) to control inflammation can reduce the risk of cardiovascular disease.
Chung‐Yuan Hsu +8 more
doaj +1 more source